Apr 5
|
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
|
Apr 4
|
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
|
Apr 4
|
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
|
Apr 4
|
2 Potentially Explosive Stocks to Buy in April
|
Apr 4
|
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
|
Apr 2
|
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
|
Apr 2
|
Could Viking Therapeutics Stock Be a Millionaire Maker?
|
Apr 2
|
The 3 Best Biotech Stocks to Buy in April 2024
|
Apr 1
|
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
|
Apr 1
|
Zacks Investment Ideas feature highlights: SPDR S&P Biotech ETF, iShares Biotech ETF, Viking Therapeutics and Madrigal Pharmaceuticals
|
Mar 31
|
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
|
Mar 31
|
5 Top Stocks to Buy in April
|
Mar 30
|
The 3 Best Russell 2000 Stocks to Buy in Q2 2024
|
Mar 29
|
Is It Too Late to Buy Viking Therapeutics Stock?
|
Mar 29
|
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
|
Mar 29
|
Why Viking Therapeutics Stock Was Rocketing Higher This Week
|
Mar 28
|
Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
|
Mar 28
|
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
|
Mar 28
|
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
|
Mar 27
|
3 Biotech Stocks to Buy on the Dip: March 2024
|